Damania B., Kenney S.C., Raab-traub N. 2023. Epstein–Barr virus (EBV): Biology and clinical disease. Cell. 185 (20), 3652–3670. https://doi.org/10.1016/j.cell.2022.08.026
Smit G., Wallis G., Griffiths P. 2019. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev. Med. Virol. 29 (3), 1–6. https://doi.org/10.1002/rmv.2034
Müller-Durovic B., Grählert J., Devine O.P., Akbar A.N., Hess C. 2019. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany N.Y.). 11 (2), 724–740. https://doi.org/10.18632/aging.101774
Png Y.T., Zhi A., Yang Y., Lee M.Y., Jahn M., Chua M., Lim C.M. 2021. The Role of NK cells in EBV infection and EBV-associated. Viruses. 13 (2), 1–22. https://doi.org/10.3390/v13020300
Cobbs C. 2019. ScienceDirect cytomegalovirus is a tumor-associated virus: Armed and dangerous. Curr Opin Virol. 39, 49–59. https://doi.org/10.1016/j.coviro.2019.08.003
Park K.H., Ryu J.H., Bae H., Yun S., Jang J.H., Han K., Cho B.S., Kim H., Lee H., Oh E. 2020. Delayed NK cell reconstitution and reduced NK activity increased the risks of CMV disease in allogeneic-hematopoietic stem cell transplantation. Int. J. Mol. Sci. 21 (10), 3663. https://doi.org/10.3390/ijms21103663
Article PubMed PubMed Central CAS Google Scholar
Kovalenko E.I., Streltsova M.A. 2016. Adaptive properties of natural killer cells – lymphocytes of innate immunity. Bioorganicheskaya Khimia (Rus.). 42 (6), 649–667. https://doi.org/10.7868/s0132342316060063
Zvereva M.I., Shcherbakova D.M., Dontsova O.A. 2010. Telomerase: Structure, functions, and activity regulation. Biochem. 75 (13), 1563–1583. https://doi.org/10.1134/S0006297910130055
Fujisaki H., Kakuda H., Imai C., Mullighan C.G., Campana D. 2009. Replicative potential of human natural killer cells. Br. J. Haematol. 145 (5), 606–613. https://doi.org/10.1111/j.1365-2141.2009.07667.x
Article PubMed PubMed Central CAS Google Scholar
Romaniuk A., Paszel-Jaworska A., Totoń E., Lisiak N., Hołysz H., Królak A., Grodecka-Gazdecka S., Rubiś B. 2019. The non-canonical functions of telomerase: To turn off or not to turn off. Mol. Biol. Rep. 46 (1), 1401–1411. https://doi.org/10.1007/s11033-018-4496-x
Article PubMed CAS Google Scholar
Schafer K.A. 1998. Veterinary pathology online. Vet. Pathol. 35(6), 461–478. https://doi.org/10.1177/030098589803500601
Article PubMed CAS Google Scholar
Gotthardt D., Trifinopoulos J., Sexl V., Putz E.M. 2019. JAK/STAT Cytokine signaling at the crossroad of NK cell development and maturation. Front. Immunol. 10, 2590. https://doi.org/10.3389/fimmu.2019.02590
Article PubMed PubMed Central CAS Google Scholar
Erokhina S.A., Streltsova M.A., Kanevskiy L.M., Telford W.G., Sapozhnikov A.M., Kovalenko E.I. 2018. HLA-DR+ NK cells are mostly characterized by less mature phenotype and high functional activity. Immunol. Cell Biol. 96 (2), 212–228. https://doi.org/10.1111/imcb.1032
Article PubMed CAS Google Scholar
Community T.G. 2024. The Galaxy platform for accessible, reproducible, and collaborative data analyses: 2024 update. Nucleic Acids Res. 52 (W1), 83–94. https://doi.org/10.1093/nar/gkae410
Love M.I., Huber W., Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15 (12), 1–21. https://doi.org/10.1186/s13059-014-0550-8
Kanehisa M., Furumichi M., Tanabe M., Sato Y., Morishima K. 2017. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucl. Acids Res. 45 (D1), 353–361. https://doi.org/10.1093/nar/gkw1092
Herbert B., Hochreiter A.E., Wright W.E., Shay J.W. 2006. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Nat. Protoc. 1 (3), 1583–1590. https://doi.org/10.1038/nprot.2006.239
Article PubMed CAS Google Scholar
Palamarchuk A.I., Kovalenko E.I., Streltsova M.A. 2024. The hTERT and iCasp9 transgenes affect EOM-ES and T-BET levels in NK cells and the introduction of both genes improves NK cell proliferation in response to IL2 and IL15 stimulation. Biomedicines. 12(3), 650–671. https://doi.org/10.3390/biomedicines12030650
PubMed PubMed Central CAS Google Scholar
Engeland K. 2022. Cell cycle regulation: p53-p21-RB signalling. CDDpress. 29 (5), 946–960. https://doi.org/10.1038/s41418-022-00988-z
Sansam C.L., Cruz N.M., Danielian P.S., Amsterdam A., Lau M.L., Hopkins N., Lees J.A. 2010. A vertebrate gene, ticrr, is an essential checkpoint and replication regulator. Genes Dev. 24 (2), 183–194. https://doi.org/10.1101/gad.1860310
Article PubMed PubMed Central CAS Google Scholar
Ahmed A., Shamsi A., Mohammad T., Mustafa G., Asimul H., Imtaiyaz I. 2021. Aurora B kinase: A potential drug target for cancer therapy. J. Cancer Res. Clin. Oncol. 147 (8), 2187–2198. https://doi.org/10.1007/s00432-021-03669-5
Article PubMed PubMed Central CAS Google Scholar
Cheeseman I.M. 2014. The kinetochore. Cold Spring Harb. Lab. Press. 6 (7), 1–18. https://doi.org/10.1101/cshperspect.a015826
Golov A.K., Gavrilov A.A. 2024. Cohesin complex: Structure and principles of interaction with DNA. Biochem. 89 (4), 585–600. https://doi.org/10.1134/S0006297924040011
Aguilera P., López-contreras A.J. 2023. Trends in gGenetics ATRX, a guardian of chromatin. Trends Genet, 39 (6), 505–519. https://doi.org/10.1016/j.tig.2023.02.009
Article PubMed CAS Google Scholar
Manuscript A. 2011. Negative regulation of CHK2 activity by protein phosphatase 2A is modulated by DNA damage. Cell Cycle. 9 (4), 736–747. https://doi.org/10.4161/cc.9.4.10613
Marongiu L., Allgayer H. 2022. Viruses in colorectal cancer. Mol. Oncol. 16 (7), 1423–1450. https://doi.org/10.1002/1878-0261.13100
Article PubMed CAS Google Scholar
Boudreau J.E., Hsu K.C. 2018. natural killer cell education and the response to infection and cancer therapy: Stay tuned. Trends Immunol. 39 (3), 222–239. https://doi.org/10.1016/j.it.2017.12.001
Article PubMed PubMed Central CAS Google Scholar
Siegler E.L., Zhu Y., Wang P., Yang L. 2018. Off-the-shelf CAR-NK cells for cancer immunotherapy. Cell Stem Cell. 23 (2), 160–161. https://doi.org/10.1016/j.stem.2018.07.007
Article PubMed CAS Google Scholar
Palamarchuk A.I., Kovalenko E.I., Streltsova M.A. 2023. Multiple actions of telomerase reverse transcriptase in cell death regulation. Biomed. Rewiev. 11 (4), 1091. https://doi.org/10.3390/biomedicines11041091
Yan J., Zhou Y., Chen D.X., Li L.L., Yang X., You Y., Ling X. 2015. Effects of mitochondrial translocation of telomerase on drug resistance in hepatocellular carcinoma cells. J. Cancer. 6 (2), 151–159. https://doi.org/10.7150/jca.10419
Article PubMed PubMed Central Google Scholar
Ma Y., Li X., Kuang E. 2016. Viral evasion of natural killer cell activation. Viruses. 8 (4), 95. https://doi.org/10.3390/v8040095
Comments (0)